Ranjeev Krishana
Director/Board Member presso BEIGENE, LTD.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Ranjeev Krishana is an Independent Non-Executive Director at BeiGene Ltd.
and a Director at Sironax Ltd.
He previously worked as a Director at Pfizer Inc. from 2004-2007 and as a Senior Regional Director from 2008-2011.
He was also the Head of International Investments at Baker Bros.
Advisors LP.
Prior to that, he worked as a Consultant at Andersen Consulting (Minnesota) from 1995-1997 and as a Manager at Accenture LLC from 1995-2001.
Krishana received his undergraduate degree from Brown University in 1995 and his graduate degree from Harvard University in 2001.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BEIGENE LTD
-.--% | 15/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Ranjeev Krishana
| Società | Posizione | Inizio |
|---|---|---|
| BEIGENE, LTD. | Director/Board Member | 01/10/2014 |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Director/Board Member | - |
Precedenti posizioni note di Ranjeev Krishana
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/04/2011 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2007 |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Corporate Officer/Principal | 01/01/2001 |
| Andersen Consulting (Minnesota) | Corporate Officer/Principal | 01/01/1997 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Portfolio Manager-Equities | - |
Formazione di Ranjeev Krishana
| Brown University | Undergraduate Degree |
| Harvard University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Aziende private | 4 |
|---|---|
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
| Andersen Consulting (Minnesota) | |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Commercial Services |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Borsa valori
- Insiders
- Ranjeev Krishana
